- HER2 Evaluation and Its Impact on Breast Cancer Treatment DecisionsK.A.B. Goddard; S. Weinmann; K. Richert-Boe; C. Chen; J. Bulkley; C. WaxPublic Health Genomics, 2012, 15(1): 1-10.
- Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in LibyaEramah, Ermiah; Abdelbaset, Buhmeida; Fathi, Abdalla; Ben Romdhane, Khaled; Nada, Salem; Seppo, Pyrhönen; Yrjö, CollanJournal of Cancer, 2012, 3: 421-431.被引 12
- Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric CancerQiu Miao Zhen; Shi Si Mei; Chen Min; Wang Jing; Wu Qi Nian; Sheng Hui; Zhang Hui Zhong; Yun Jing Ping; Zhou Zhi Wei; Wang Feng Hua; Yang Da Jun; Xu Rui HuaJournal of Cancer, 2017, 8(17): 3531-3537.
期刊论文
Comparison between her2, estrogen receptors and progesterone receptors in primary breast carcinomas and matched lymph node metastases
10阅读
